Jiansheng Lu

National Key Laboratory Of Advanced Biotechnology
Beijing, 100071, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Oligomerized receptor binding domain blocks pan-sarbecovirus infection via enhanced avidity to host receptor.

Oligomerized receptor binding domain blocks pan-sarbecovirus infection via enhanced avidity to host receptor.

Journal: Antiviral research

Published: April 01, 2026

Proteolytic Activities and Immunological Effects of Light Chains of Botulinum Neurotoxin A1, A2 and A3 Subtypes.

Proteolytic Activities and Immunological Effects of Light Chains of Botulinum Neurotoxin A1, A2 and A3 Subtypes.

Journal: Toxins

Published: November 18, 2025

Humanized VHH-hFc Fusion Proteins Targeting the L-HN Fragment of Tetanus Toxin Provided Protection In Vivo.

Humanized VHH-hFc Fusion Proteins Targeting the L-HN Fragment of Tetanus Toxin Provided Protection In Vivo.

Journal: Antibodies (Basel, Switzerland)

Published: April 14, 2025

Anti-Tumor Activities of Anti-Siglec-15 Chimeric Heavy-Chain Antibodies.

Anti-Tumor Activities of Anti-Siglec-15 Chimeric Heavy-Chain Antibodies.

Journal: International journal of molecular sciences

Published: April 03, 2025

Fluorescence Reduction Neutralization Test: A Novel, Rapid, and Efficient Method for Characterizing the Neutralizing Activity of Antibodies Against Dengue Virus.

Fluorescence Reduction Neutralization Test: A Novel, Rapid, and Efficient Method for Characterizing the Neutralizing Activity of Antibodies Against Dengue Virus.

Journal: Current issues in molecular biology

Published: January 22, 2025

A hTfR1 Receptor-Specific VHH Antibody Neutralizes Pseudoviruses Expressing Glycoproteins from Junín and Machupo Viruses.

A hTfR1 Receptor-Specific VHH Antibody Neutralizes Pseudoviruses Expressing Glycoproteins from Junín and Machupo Viruses.

Journal: Viruses

Published: October 23, 2024

Neutralizing chimeric heavy-chain antibody targeting the L-HN domain of Clostridium botulinum neurotoxin type F.

Neutralizing chimeric heavy-chain antibody targeting the L-HN domain of Clostridium botulinum neurotoxin type F.

Journal: Archives of toxicology

Published: July 07, 2024

Characterization of neutralizing chimeric heavy-chain antibodies against tetanus toxin.

Characterization of neutralizing chimeric heavy-chain antibodies against tetanus toxin.

Journal: Human vaccines & immunotherapeutics

Published: June 27, 2024

Neutralizing chimeric anti-F1 monoclonal antibody against Yersinia pestis infection.

Neutralizing chimeric anti-F1 monoclonal antibody against Yersinia pestis infection.

Journal: International journal of antimicrobial agents

Published: June 11, 2024

New Engineered-Chimeric Botulinum Neurotoxin Mutant Acts as an Effective Bivalent Vaccine Against Botulinum Neurotoxin Serotype A and E.

New Engineered-Chimeric Botulinum Neurotoxin Mutant Acts as an Effective Bivalent Vaccine Against Botulinum Neurotoxin Serotype A and E.

Journal: Immunology

Published: May 01, 2024

Establishment of the First National Standard for Neutralizing Antibodies against SARS-CoV-2 XBB Variants.

Establishment of the First National Standard for Neutralizing Antibodies against SARS-CoV-2 XBB Variants.

Journal: Viruses

Published: March 16, 2024

Isolation and characterization of Hc-targeting chimeric heavy chain antibodies neutralizing botulinum neurotoxin type B.

Isolation and characterization of Hc-targeting chimeric heavy chain antibodies neutralizing botulinum neurotoxin type B.

Journal: Frontiers in immunology

Published: February 02, 2024

Showing 1-12 of 26

Last Updated: 09/26/2026